Quantum BioPharma Ltd. (QNTM)
2.82
-0.12
(-4.08%)
USD |
NASDAQ |
Oct 12, 16:00
2.81
-0.01
(-0.35%)
After-Hours: 20:00
Quantum BioPharma Total Assets (Quarterly) : 14.39M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.39M |
| March 31, 2026 | 14.93M |
| December 31, 2025 | 11.16M |
| September 30, 2025 | 14.15M |
| June 30, 2025 | 15.30M |
| March 31, 2025 | 14.87M |
| December 31, 2024 | 17.12M |
| September 30, 2024 | 19.03M |
| June 30, 2024 | 15.25M |
| March 31, 2024 | 15.44M |
| December 31, 2023 | 17.47M |
| September 30, 2023 | 18.94M |
| June 30, 2023 | 21.41M |
| March 31, 2023 | 29.48M |
| December 31, 2022 | 38.41M |
| September 30, 2022 | 43.58M |
| June 30, 2022 | 51.17M |
| Date | Value |
|---|---|
| March 31, 2022 | 55.71M |
| December 31, 2021 | 62.96M |
| September 30, 2021 | 68.67M |
| June 30, 2021 | 68.35M |
| March 31, 2021 | 76.44M |
| December 31, 2020 | 41.97M |
| September 30, 2020 | 42.08M |
| June 30, 2020 | 38.19M |
| March 31, 2020 | 34.94M |
| December 31, 2019 | 43.22M |
| September 30, 2019 | 52.97M |
| June 30, 2019 | 54.71M |
| March 31, 2019 | 38.18M |
| December 31, 2018 | 38.64M |
| September 30, 2018 | 51.51M |
| June 30, 2018 | 40.14M |
| March 31, 2018 | 11.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Numinus Wellness, Inc. | 1.852M |
| Cocrystal Pharma, Inc. | 4.649M |
| Edesa Biotech, Inc. | 12.72M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| Invion Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.298M |
| Shareholders Equity (Quarterly) | 7.949M |
| Debt to Equity Ratio | 0.1212 |
| Current Ratio | 1.200 |
| Net Debt Paydown Yield | 0.23% |